Praxis Precision Medicines, Inc.
PRAX
Pozycja w akcjach
#2591
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the... Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which is currently in Phase IIa clinical trials for addressing both major depressive disorder and perimenopausal depression. Additionally, PRAX-944, a small molecule designed to selectively inhibit T-type calcium channels, is also progressing through Phase IIa clinical trials to manage essential tremor. Beyond these, Praxis is also advancing a pipeline of other promising drug candidates, such as: PRAX-562, a persistent sodium current blocker, undergoing Phase I clinical evaluation for treating severe pediatric epilepsy and adult cephalgia (headaches). PRAX-222, an antisense oligonucleotide (ASO) aimed at individuals suffering from gain-of-function (GOF) SCN2A epilepsy. And a program targeting KCNT1 for the treatment of KCNT1 GOF epilepsy. To further its research and development efforts, Praxis maintains several strategic alliances. These include a cooperation and licensing arrangement with RogCon Inc.; a licensing deal with Purdue Neuroscience Company; a comprehensive research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and a collaborative project with The Florey Institute focused on the creation of three new antisense oligonucleotides (ASOs). Established in 2015, the company's headquarters are situated in Boston, Massachusetts.
Cena akcji
$267.97
Kapitalizacja rynkowa
$7.48B
Zmiana (1 dzień)
3.00%
Zmiana (1 rok)
53.06%
Kraj
US
Handel Praxis Precision Medicines, Inc. (PRAX)
Kategoria
Healthcare
Liczba akcji w obrocie dla Praxis Precision Medicines, Inc. (PRAX)
Liczba akcji w obrocie na dzień June 2026: 29.13M
Zgodnie z najnowszymi raportami finansowymi i ceną akcji Praxis Precision Medicines, Inc., aktualna liczba akcji w obrocie to 29.13M. Na koniec December 2023 firma posiadała 6.59M akcji w obrocie. Liczba akcji w obrocie jest zwykle kształtowana przez podziały akcji i skupy akcji.
Historia liczby akcji w obrocie dla Praxis Precision Medicines, Inc. (PRAX) od 2018 do 2026
Akcje w obrocie na koniec każdego roku
| Rok | Akcje w obrocie | Zmień |
|---|---|---|
| 2026 (TTM) | 29.13M | 62.68% |
| 2024 | 17.91M | 171.55% |
| 2023 | 6.59M | 114.58% |
| 2022 | 3.07M | 8.58% |
| 2021 | 2.83M | 374.34% |
| 2020 | 596.68K | 485.12% |
| 2019 | 101.98K | 17.88% |
| 2018 | 86.51K | 0.00% |
Akcje w obrocie dla podobnych firm lub konkurentów
| Firma | Akcje w obrocie | Różnica | Kraj |
|---|---|---|---|
| 253.90M | 771.57% |
US
|
|
| 396.00M | 1,259.36% |
US
|
|
| 478.91M | 1,543.97% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 113.47% |
NL
|
